Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency

Affiliations

• ¹ Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solovyova@mskcc.org.
• ² ROME Therapeutics, Inc., Boston, MA, USA.
• ³ Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁴ Acorn Biosciences, Cambridge, MA, USA.
• ⁵ Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
• ⁶ Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ⁷ Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ⁸ Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. greenbab@mskcc.org.
• ⁹ Physiology, Biophysics & Systems Biology, Weill Cornell Medical College, New York, NY, USA. greenbab@mskcc.org.